CD8A and cancer: To investigate the underlying antitumor mechanism of FeMOF-based cancer vaccines, the spleens of mice at the endpoint of antitumor experiments were collected to check CD4+, CD8+ and tetramer+CD8+ T cell populations (Figures 4C, D).